OGC
ABBV icon

Oak Grove Capital’s AbbVie ABBV Stock Holding History

Oak Grove Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-100
Closed -$14K – 79
2021
Q4 		$14K Hold
100
– – ﹤0.01% 109
2021
Q3 		$2K Hold
100
– – ﹤0.01% 105
2021
Q2 		$2K Hold
100
– – ﹤0.01% 108
2021
Q1 		$2K Sell
100
-700
-88% -$74.9K ﹤0.01% 99
2020
Q4 		$3K Buy
+800
New +$76.9K ﹤0.01% 82
2020
Q3 		– Sell
-200
Closed -$2K – 59
2020
Q2 		$2K Buy
+200
New +$17.6K ﹤0.01% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Oak Grove Capital's ABBV Position: Q2 2026 in Review

Oak Grove Capital opened a new position in AbbVie (ABBV) in Q2 2026: 44,750 shares worth $11.3M. The stake represents 0.54% of the portfolio and ranks #33 among its holdings. This is a return to the name: Oak Grove Capital previously reported a position in ABBV as recently as Q1 2023.

Oak Grove Capital first reported a position in ABBV in Q1 2018 and has held it in 19 quarters since. The position peaked at $23.2M in Q1 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Oak Grove Capital held 44,750 shares of AbbVie worth $11.3M as of Q2 2026.
  • AbbVie was a new Oak Grove Capital position in Q2 2026.
  • AbbVie made up 0.54% of Oak Grove Capital's portfolio in Q2 2026, its #33 holding.
  • Oak Grove Capital first reported a position in AbbVie in Q1 2018 and has held it in 19 quarters since.
  • Oak Grove Capital's AbbVie position peaked at $23.2M in Q1 2022.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Oak Grove Capital's 13F filing for Q2 2026, filed 13 Aug 2026.